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AntioxidantEstrogens have antioxidant properties which are due to their ability to bind to estrogen receptors and to up-
regulate the expression of antioxidant enzymes via intracellular signalling pathways. Mitochondria are key
organelles in the development of age-associated cellular damage. Recently, estrogen receptors were
identiﬁed in mitochondria. The aim of this paper was to test whether estradiol directly affects mitochondria
by preventing oxidative stress and protecting frail mitochondria. Incubation with estradiol at normal
intracellular concentrations prevents the formation of reactive oxygen species by mitochondria in a saturable
manner. Moreover, estradiol protects mitochondrial integrity as indicated by an increase in mitochondrial
membrane potential. It also prevents the apoptogenic leakage of cytochrome c from mitochondria and as a
result the mitochondrial content of this cytochrome c is maintained high. Thus, estradiol prevents the onset
of the mitochondrial pathway of apoptosis by a direct effect on the organelle. Genistein, a phytoestrogen
present at high concentration in soy, mimics the protective effect of estradiol by both decreasing the rate of
formation of reactive oxygen species and preventing the release of cytochrome c from mitochondria.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The role of mitochondria as key organelles involved in ageing was
proposed by Miquel et al. [1]. This concept was experimentally
conﬁrmed in many laboratories including our own. Some years ago,
work from our laboratory [2] and that of Hagen et al. [3] showed that
mitochondria are frail in cells of old animals and that they decay with
age. Moreover we found that oxidation of mitochondrial glutathione
correlates with an increase in the amount of 8-oxoguanosine, an
oxidized form of guanosine which is mutagenic. The role of
mitochondria in aging has been highlighted in recent years [4].
Mitochondria are both sources and targets of damage by free radicals.
These highly reactive molecules are generated in mitochondria and
because of their very high reactivity they cause damage to
mitochondrial structures.
Further proof of the role of mitochondria in aging came from
studies on the different longevity between genders. Females in many
species (including humans) live longer than males. We showed that
oxidant production by mitochondria from males is much higher than
from females [5]. This is due to the action of estrogens which up-
regulate nuclear gene expression of antioxidant enzymes which are
directed to mitochondria [5–7]. Moreover, we showed that the
antioxidant action of estrogens in vivo is due, not to their chemical
phenolic structure, but rather to their interaction with estrogen34963864642.
.
ll rights reserved.receptors in cells which eventually lead to the activation of mitogen
activated protein kinases (MAPK) and nuclear factor kappa B (NFκB)
[8,9].
However, proof of a direct effect of estrogens on mitochondria was
lacking. Experimental evidence shows, however, that other hor-
mones, such as melatonin act directly on these organelles [10];
moreover estrogen receptors are present in mitochondria [11]. We
hypothesized that estrogens (and phytoestrogens), in addition to
their well-established protective effects mediated by the up-regula-
tion of antioxidant genes.
The aim of this work was to test if estrogens protect mitochondria
in a direct fashion i.e. independently of nuclear or cytosolic
interactions.
2. Material and methods
2.1. Animals
Male Wistar rats between 4 and 6 months of age were used.
Animals were housed at constant temperature and humidity and with
a 12 h light/12 h dark cycle. They were fed on a standard laboratory
diet (containing 590 g carbohydrates, 30 g lipids, and 160 g protein
per kilogram of diet) and tap water ad libitum.
In all cases, animals were treated in accordance with the principles
for the good care of laboratory animals.
2.2. Isolation of mitochondria
After the animals were sacriﬁced by cervical dislocation, their
livers and brains were quickly removed. Liver mitochondria were
Fig. 1. Effects of ovariectomy and 17β-estradiol on peroxide production by synaptic and
non-synaptic brain mitochondria. Mitochondria were incubated with 10 mM succinate
or 5 mMpyruvate plus 2.5 mMmalate. Values denote the mean±S.D. of measurements
from n different animals: synaptic mitochondria (n=3–5) and non-synaptic
mitochondria (n=3–5). The statistical difference is indicated as follows: ⁎pb0.05 vs.
control female rats; #pb0.05 vs. ovariectomy.
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[12]. Brieﬂy, minced liver fragments were homogenized, centrifuged
at 1000g for 19′. This was repeated three times to remove cell debris.
Supernatants were then centrifuged at 10,000g for 19′ to purify
mitochondria. Synaptic and non-synaptic mitochondria were isolated
following themethod of Lai and Clark [13]. This is based on differential
centrifugations using different concentrations of ﬁcoll to separate
synaptosomes from non-synaptic fraction.
2.3. Mitochondrial incubation conditions
Isolated mitochondria from males were incubated at 37 °C in a
buffer solution containing 0.3 M sucrose, 1 mM EGTA, 5 mM MOPS,
14.7 μM BSA, 5 mM KH2PO4, pH 7.4, for 30 min, 1, 2 or 4 h.
Depending on the experiment, we added 0.02–2000 nM estradiol,
0.2 nM estradiol-BSA, 0.5 μM genistein, or 1 μM cyclosporin A (CsA) to
the incubation buffer.
Concentrations were chosen following previously published data:
brieﬂy, estradiol was incubated at normal intracellular concentration
[8] and genistein at nutritionally relevant concentration (i.e. that
found in the blood of far Eastern population) [8,14,15].
2.4. Peroxide production
The rate of peroxide production was determined in isolated
mitochondria using a modiﬁcation of the method described by Barja
de Quiroga [16] and according to Borras et al. [5]. Brieﬂy, mitochon-
dria were incubated at 37 °C with 10 mM succinate or 5 mM pyruvate
plus 2.5 mM malate in 2 ml of phosphate buffer, pH 7.4, containing
0.1 mM EGTA, 5 mM KH2PO4, 3 mM MgCl2, 145 mM KCL, 30 mM
HEPES, 0.1 mM homovanílico acid, and 6 U/ml horseradish peroxi-
dase. The incubation was stopped at 5, 10, and 15 min with 1 ml of
cold 2 M glycine buffer containing 50 mM EDTA and 2.2 M NaOH. The
ﬂuorescence of supernatants was measured using 312 nm as
excitation wavelength and 420 nm as emission wavelength. The
rate of peroxide production was calculated using a standard curve
of H2O2.
2.5. Mitochondrial membrane potential
Mitochondrial membrane potential was determined by ﬂow
cytometry. We used an EPICS ELITE cell sorter (Coulter Electronics,
Hialeah, FL). Fluorochromes were from Lambda Fluoreszenz Techno-
logie GmbH (Graz, Austria). Fluorochromes were excited with an
argon laser tuned at 488 nm. Samples were acquired for 10,000
individual mitochondria. Mitochondrial membrane potential was
determined using the ﬂuorescent dye rhodamine 123(Rh123) at
525±5 nm ﬂuorescence emission [17].
2.6. Cytochrome c determination
Cytochrome c levels were determined by Western blotting in
cytosolic and in mitochondrial fractions. Immediately after incubation
for one hour with estradiol or genistein, aliquots of cell lysate (40 μg)
were boiled for 10 min to inactivate proteases and phosphatases,
electrophoresed in SDS–12.5% polyacrylamide gels and blotted onto
an Immun-Blot PVDF Membrane (BIO-RAD, USA). Membranes were
incubated with primary antibody against cytochrome c (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) overnight at 4 °C. Thereafter, the
blots were washed three times for 5 m each with a wash buffer (PBS
containing 0.2% Tween 20) at room temperature and then further
incubated for 1 h with a secondary horseradish peroxidase (HRP)-
linked anti-mouse IgG antibody (Cell Signaling Technologies, IZASA,
Barcelona, Spain ). The blots were again washed and developed using
the LumiGLO® reagent as speciﬁed (Cell Signaling Technologies
IZASA, Barcelona, Spain). Autoradiographic signals were assessedusing a Fujiﬁlm scanning densitometer (Fujiﬁlm LAS-1000 Plus, Fuji
Madrid, Spain).
2.7. Statistics
Results are expressed as mean±SD. Statistical analysis was
performed by the least-signiﬁcant difference test which consists of
two steps: First an analysis of variance was performed. The null
hypothesis was accepted for all numbers of those set in which F was
non-signiﬁcant at the level of p≤0.05. Second, the sets of data in
which F was signiﬁcant were examined by the modiﬁed t-test using
p≤0.05 as the critical limit.
3. Results
3.1. Estradiol decreases peroxide production and increases membrane
potential in isolated mitochondria
We have previously reported that the peroxide production by
isolated mitochondria is signiﬁcantly lower in females than in males
[5]. In fact, we have found that females produce as low as 50% less
peroxide than males when incubated in the presence of 10 mM
succinate.
Moreover, we have studied the different rates of peroxide
production in synaptic and non-synaptic mitochondria from brain.
Fig. 1 shows that synaptic mitochondria (mainly from neurons)
produce many more peroxides than non-synaptic ones (mainly from
glia). In this tissue, i.e. brain, it is also apparent that males produce
approximately twice the amount of peroxides when compared with
females. This is, however, completely prevented by ovariectomy. In
fact, ovariectomised females produce as much or even more peroxide
than males. We would like to point out that synaptic mitochondria
come from tissues which are mainly post-mitotic whereas non-
synaptic ones come from cells which still have the capacity to divide.
Neurons may divide in vivo and this has been recently shown
including the fact that neuronal stem cells which are produced in the
hippocampus may migrate, at least in the rat, to the olfactory bulb
[18]. However, this is only a tiny proportion of the total amount of
neurons in brain of the adult animal which are predominantly post-
mitotic. Another interesting point is that ovariectomy causes a very
signiﬁcant upshot of the production of peroxides. We previously
observed [5] that this is due to the fact that oestrogens up-regulate
antioxidant genes such as superoxide dismutase or glutathione
peroxidase.
Thus, oestrogens not only protect against oxidative stress in
hepatic mitochondria but also in brain (synaptic and non-synaptic)
mitochondria. There must be common mechanisms for the protective
action of oestrogens in two very different tissues such as liver or brain
and we have shown that this is due to the up-regulation of the
antioxidant genes as stated above.
Table 1
Prevention of age-associated mitochondrial impairment by treatment with a Ginkgo
biloba extract.
Young Old Old-treated
Peroxide production
(% vs. young)
100 116±8⁎ 105±6#
OXO-8-Deoxyguanosine
(pmol/μg mtDNA)
0.58±0.21 1.29±0.20⁎ 0.49±0.13#
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only via interaction with conventional receptors or also via a direct
effect in mitochondria. To test this, we incubated mitochondria from
males with various concentrations of estradiol and found that
peroxide production is signiﬁcantly lower when mitochondria are
incubated in the presence of 0.2 nM or above. Moreover, this effect is
saturable. Fig. 2 shows that concentrations of 0.2 nM or above (up to
2000 nM) decrease peroxide production to levels of approximately
30% of the controls, but no more. The fact that this effect shows a
saturation curve indicates that estradiol may act via interaction with
speciﬁc receptors present in mitochondria.
As we have shown above, hepatic and brain mitochondria have
quite a number of common mechanisms in terms of the control of
their peroxide production. Thus, after studying the direct protective
effect of estradiol in hepatic mitochondria, we turned to brain
mitochondria. And indeed, we found that incubation of mitochon-
dria isolated from brains of young male rats, in the presence of
0.2 nM estradiol caused a very signiﬁcant decrease in peroxide
production. We found that this production fell from 0.145±0.023
to 0.032±0.009 (pb0.05). This is in fact one fourth of the rate we
found in controls. Thus, the direct protective effect of estradiol on
isolated mitochondria is more pronounced in brain than in liver. As
we saw in previous studies in which we determined the rate of
peroxide production in brain and liver, we ﬁnd now that basal
peroxide production by mitochondria from brain is more than
twice that of liver [5]. Again, since brain is a post-mitotic tissue, it
is likely that even in the relatively young animal; mitochondria are
more damaged than those of liver. The basal mechanisms
controlling peroxide production in brain and liver may remain
the same but the actual rate of production is much higher in brain
than in liver.
This lower peroxide production coincides with an increased
coupling of the mitochondrial respiratory chain and oxidative
phosphorylation as indicated by the mitochondrial membrane
potential, which is 45% higher in mitochondria incubated with
estradiol (0.02 nM) than in controls (pb0.05).
Adding estrogens or phytoestrogens to mitochondria is one of the
most simplistic ways to study the protection against radical
production by the organelle.
However, the importance of the direct effect of estrogenic
compounds on mitochondria relies also on being able to observe
these protective effects in cells and eventually in whole animals.
Correlation between cellular protection studies such as those reported
here must correlate with in vivo studies. In fact, we observe that
feeding animals with a Ginkgo biloba extract (EGB791, which is aFig. 2. Estradiol decreases hydrogen peroxide production by isolated hepatic
mitochondria. The rate of peroxide production was measured in isolated hepatic
mitochondria from male Wistar rats (3–5 months old). Values denote the mean±S.D.
of measurements from 6 to 10 different animals. The statistical difference is indicated as
follows: ⁎pb0.05; ⁎⁎pb0.01 vs. control. E2 means incubation with 17β-estradiol at
corresponding concentration.standard diet extract from Ginkgo biloba) offers a signiﬁcant
protection against oxidative stress in mitochondria and even
mitochondrial DNA damage. Table 1 shows that the rate of peroxide
generation by old animals is signiﬁcantly higher than that of young
ones, but animals treated with EGB761 show peroxide production
rates very close to those of controls. Not only does peroxide
production increase with ageing and is prevented by administration
of Ginkgo extract but also the actual multigenic damage to DNA as
determined by measuring the levels of 8-oxo-deoxi-guanosine
reﬂects signiﬁcant protection by Ginkgo biloba. Table 1 shows that
mitochondrial DNA from old animals is signiﬁcantly more oxidised
than that of controls and indeed feeding with Ginkgo biloba protects
against such damage.
3.2. Estradiol prevents loss release of cytochrome c from mitochondria
A critical function of mitochondria is the control of cell viability via
the apoptotic process. In fact, the release of cytochrome c is a key sub-
cellular event to unleash cellular apoptosis. Moreover, increased
mitochondrial levels of cytochrome c may act as antioxidant because
by increasing the ﬂow of electrons through the respiratory chain, a
lower rate of oxidant production may be expected.
Fig. 3, Panel a shows that estradiol, either free or bound to bovine
serum albumin, signiﬁcantly increases the amount of cytochrome c
present in mitochondria after one hour incubation. The effect is as
marked as when mitochondria are incubated with cyclosporine A.
Consequently, the release of cytochrome c to the supernatant is
decreased when mitochondria are incubated with estradiol (either
free or bound to bovine serum albumin) as shown in Fig. 3, Panel b.
Thus, it appears that estradiol prevents the release of cytochrome c
thus having two functions, one being to prevent the onset of apoptosis
and the other being to prevent, or at least decrease, oxidant
production by mitochondria.
3.3. Genistein decreases oxidant production and cytochrome release
from isolated mitochondria
Genistein is a soy isoﬂavone which binds to estrogen receptors
(especially ERβ). We have recently shown that it may mimic many of
the favourable effects of estradiol when incubated with cells (either
alone, [19], or in the presence of amyloid beta peptide, [20]).
Therefore, we tested whether genistein could mimic the effects of
estradiol on peroxide production by mitochondria as well as on
cytochrome c release from the organelle.
Fig. 4 shows that 0.5 μMof genistein, when incubated with isolated
mitochondria, causes a lowering in the rate of peroxide production
that is similar to that of estradiol.
In a similar fashion, 0.5 μM genistein prevents cytochrome c
release from mitochondria. Fig. 5, Panel a shows that the levels of
cytochrome c are higher in mitochondria incubated with genistein
than in controls and conversely the levels of cytochrome c in the
incubation medium are lower than those in controls (see Fig. 5,
Panel b).
These effects are essentially comparable to those of estradiol and
therefore our results indicate that genistein is as effective as estradiol
to protect isolated mitochondria.
Fig. 5. Genistein is as effective as estradiol in inhibiting cytochrome c release from
mitochondria. (a) The level of cytochrome c was measured in isolated hepatic
mitochondria from male Wistar rats (3–5 months old). Values denote the mean±S.D.
of measurements from 4 different animals. The statistical difference is indicated as
follows: ⁎pb0.05 or ⁎⁎pb0.01 vs. control. Estradiol means 0.2 nM 17β-estradiol and
genistein concentration is 0.5 μM; 1 μM CsA means cyclosporine A. (b) The level of
cytochrome cwas measured in supernatant of isolated hepatic mitochondria frommale
Wistar rats (3-5 months-old). Values denote the mean±S.D. of measurements from 4
different animals. The statistical difference is indicated as follows: ⁎pb0.05 vs. control.
Estradiol means 0.2 nM 17β-estradiol and genistein concentration is 0.5 μM; 1 μM CsA
means cyclosporine A.
Fig. 3. Estradiol inhibits cytochrome c release from mitochondria. (a) The level of
cytochrome c was measured in isolated hepatic mitochondria from male Wistar rats
(3–5 months old). Values denote the mean±S.D. of measurements from 4 different
animals. The statistical difference is indicated as follows: ⁎pb0.05 vs. control. E2 means
incubation with 0.2 nM 17β-estradiol; E2-BSA means incubation with 0.2 nM 17β-
estradiol bound to bovine serum albumin; CsAmeans 1 μM cyclosporine A. (b) The level
of cytochrome c was measured in supernatant of isolated hepatic mitochondria from
male Wistar rats (3–5 months old). Values denote the mean±S.D. of measurements
from 4 different animals. The statistical difference is indicated as follows: ⁎pb0.05 vs.
control. E2 means incubation with 0.2 nM 17β-estradiol; E2-BSA means incubation with
0.2 nM17β-estradiol bound to bovine serum albumin; CsA means 1 μM cyclosporine A.
208 C. Borrás et al. / Biochimica et Biophysica Acta 1802 (2010) 205–2114. Discussion
4.1. Frailty of mitochondria upon ageing
Ever since the postulation of the mitochondrial theory of ageing by
Miquel et al. [1], these organelles have been the subject of close
attention by molecular gerontologists. A decade ago, in our laboratory
we found that mitochondria are damaged inside cells [2]. Almost
simultaneously, Ames' group also found that mitochondria decayFig. 4. Genistein is as effective as estradiol in decreasing hydrogen peroxide production
by isolated hepatic mitochondria. The rate of peroxide production was measured in
isolated hepatic mitochondria from male Wistar rats (3–5 months old). Values denote
the mean±S.D. of measurements from 6 to 10 different animals. The statistical
difference is indicated as follows: ⁎pb0.05; ⁎⁎pb0.01 vs. control. Estradiol means
0.2 nM 17β-estradiol and genistein concentration is 0.5 μM.within cells upon ageing [3]. A critical question that we raised then
and that, to our knowledge has not yet been answered is that
mitochondria may be damaged within ageing cells because they are
frailer. Both Ames' group and our own, found that peroxide
production by mitochondria is increased during ageing [2,3].
Moreover, we recently attributed the difference in longevity between
males and females in many species including humans to a lower
peroxide production by mitochondria from females when compared
with those of males [6,21]. We showed that this is due to the fact that
estradiol activates cytosolic cell signalling pathways that up-regulate
the nuclear expression of antioxidant genes whose protein products
are directed towards mitochondria. Manganese superoxide dismutase
and glutathione peroxidase are examples of this. However, the
question of the possible direct interaction of estrogens with
mitochondria had remained unanswered. In this paper we have
performed experiments that show that estrogens protect mitochon-
dria in a direct fashion, probably by lowering their frailty, especially in
those from old animals.
4.2. Role of mitochondria in Alzheimer's disease pathophysiology
Early reports emphasized the role of amyloid plaques in
Alzheimer's pathophysiology. However, soon it became apparent
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[22]. Mitochondria were possible targets of Aβ toxicity.Work from the
groups of G. Perry and M. Smith showed that Abnormalities in
mitochondrial function occur in Alzheimer's disease [23,24]. The
group of C. Oliveira reported that Aβ lowers mitochondrial respiration
by interfering with the respiratory chain complexes [25]. Moreover,
we found that Aβ causes an increase in radical production by
mitochondria which depends on the gender of the animal [26].
4.3. Estradiol is an antioxidant in cells because it lowers peroxide
production by mitochondria
Estradiol and other related oestrogenic compounds were postu-
lated to be antioxidants because of the phenolic structure of the A
ring. While this may be true in vitro, a simple consideration of the
dose in which estradiol acts in vivo rules out the possibility that it may
be an antioxidant based strictly on its phenolic chemical properties.
For instance, a well known antioxidant such as vitamin E is usually
given at doses of approximately 500 mg per day. Estradiol, however,
when administered to a patient is given at a dose of 50 micrograms
per day. Thus, if estradiol were to be a chemical antioxidant, its
antioxidant properties should be 10,000 timesmore potent than those
of vitamin E and this is certainly not the case. Consequently, we
postulated that estrogens behave as antioxidants because of their
hormonal properties, i.e. due to the binding to estrogen receptors and
subsequent action mediated by cell signalling pathways [8]. We now
have shown (Fig. 2) that when using highly puriﬁed mitochondria, i.e.
virtually void of cytosolic components, estradiol lowers the produc-
tion of oxidants in a saturable manner. This indicates that the
hormone must act via a ligand receptor mediated mechanism.
We observe signiﬁcant reduction in the rate of peroxide production
(to approximately 30% of the controls) at concentrations of about
0.2 nM, which is the estimated physiological concentration of
estradiol within cells [15].
4.4. Estrogen receptors in mitochondria
The presence of estrogen receptors alpha and beta in mitochondria
has been recently identiﬁed. Pedram et al. [27] identiﬁed functional
receptors in mitochondria of MCF7 cells. This is a line of cells derived
from breast cancers. These authors determined the presence of
estrogen receptors in these cancer cells after stimulation with
ultraviolet radiation. In fact, estradiol proved protective against
ultraviolet irradiation of cells and the authors claimed that this was
due to a direct effect of estradiol on mitochondria. The possible
protective effect of estradiol mediated by mitochondria was also
suggested by Stirone et al. [28]. These authors proposed that nuclear
respiratory factor 1 was signiﬁcantly increased by long-term estrogen
treatment in vivo.
However, in this paper, for the ﬁrst time, we incubate highly
puriﬁed mitochondria from normal rat tissues, and not from cancer-
derived cells, and observe a clear protection against oxidative stress
generated by these mitochondria.
4.5. Estradiol, mitochondria, and cytochrome c release
Mitochondria are involved in the onset of apoptosis via the so-
called intracellular pathway. The ﬁrst event in this pathway is the
release of cytochrome c from the organelle. This has two conse-
quences: the ﬁrst is that there is more cytochrome c in the cytosol
which ultimately leads to the activation of caspases. The second is that
there is less cytochrome c in the mitochondrial membranes and
therefore the mitochondrial respiratory chain is impaired. We have
found that estradiol prevents the release of cytochrome c from
mitochondria and also increases the efﬁciency of the respiratory chain
thus increasing the mitochondrial membrane potential and decreas-ing peroxide production (see Fig. 2). Thus, a molecular explanation for
the prevention of the oxidant production by mitochondria is the
prevention of the release of cytochrome c from the mitochondrial
membrane.
4.6. Hormonal control of the mitochondrial transition pore
The direct inhibition of release of cytochrome c frommitochondria
led us to think that it might control the mitochondrial transition pore,
which is involved in the release of cytochrome c. In fact, estradiol is as
potent as cyclosporine A to prevent the release of cytochrome c from
mitochondria.
The effect of estradiol that we are reporting is not the ﬁrst to be
observed in which a lipophilic hormone prevents the opening of the
mitochondrial transition pore. Melatonin also inhibits the mito-
chondria permeability transition pore and this has been proposed
as a mechanism responsible for the antiapoptotic effect of the
hormone [10].
Thus, we believe we can postulate that estradiol prevents
oxidative stress caused by mitochondria not only via pathways
involving the cytosolic signalling pathways, but also in a direct
fashion. The mechanism that we propose is as follows: estradiol –
binds to mitochondrial estrogen receptors – inhibits the opening of
the mitochondrial transition pore – prevents the release of cyto-
chrome c from mitochondria. As a result, cytochrome c is maintained
in its “normal” location, i.e. within the internal mitochondrial
membrane allowing a normal ﬂow through the respiratory pathway
and preventing the formation of oxidants by mitochondria.
Needless to say, this mechanism is compatible with the previous
we postulated (involving membrane receptors, cytosolic signalling
pathways, and nuclear activation of genes) [8]. Both mechanisms may
be important to explain the antioxidant properties of estrogens and
eventually to help us understand why in many species, estrogens
protect cells and explain why females live longer than males.
4.7. Brain protection by estrogenic compounds
We report here that mitochondria from brain, particularly synaptic
ones, produce manymore peroxides than those from liver. In fact, this
basic fact correlates well with in vitro cellular studies and from in vivo
experiments. Evidence from the clinic is less clear.
Our report that estradiol protects against production of peroxides
by mitochondria, is in keeping with previous studies from many labs
including our own that mitochondria are protected from age-
associated damage by estrogens (for a review, see [29]) The
mechanisms by which estrogens protect against mitochondrial
damage are numerous. Many reports out the role of calcium for
mitochondrial damage associated with ageing and in fact estradiol
seemed to protect against alteration in calcium homeostasis [30]. We
report here that estradiol protects against release of cytochrome c by
isolated mitochondria. Previously, we reported that estradiol or
genistein prevented against cellular damage caused by Alzheimer's
Aβ peptide by preventing activation of p38 [20]. Aβ peptide causes
mitochondrial aggregation in neurons [26] and this has also been
shown not only in isolated mitochondria but also within cells [20].
Nevertheless, the evidence that estradiol may prevent or delay the
onset of Alzheimer's disease in the clinic is much more controversial.
So far, we cannot put forward a clear recommendation as to whether
estradiol can be used in the clinic in the prevention of Alzheimer's
disease. However, apparently the only clinical study which is showing
promising results is one in which administration of Ginkgo biloba
(which indeed contains high amounts of estrogenic compounds) is
administered to patients.
Along these lines we have found that amyloid beta peptide does
not increase the rate of oxidant production in mitochondria from
young females but it does indeed increase in brain mitochondria
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may be a source of signals for toxicity for survival in Alzheimer's
disease [31].
Clearly, more studies are required to establish whether and under
what conditions, replacement with estrogenic compounds may delay
or alleviate the symptoms of Alzheimer's disease.
4.8. Genistein mimics the protective effects of estradiol on
isolated mitochondria
A major problem facing research of the protective effects of
estrogens on biological systems is that the practical applications of
these studies are limited by the fact that estrogen replacement
therapy presents serious problems in the clinical setting. To begin
with, estradiol cannot be administered to males because of its
feminising effects. Moreover, its administration to women also
presents serious problems. It has been shown to increase the risk of
breast cancer [32], and even to increase the risk of cardiovascular
disease in the post-menopausal stage [33]. Phytoestrogens, on the
contrary, present us with the possibility of treating both men and
women. They do not show any signiﬁcant feminising effects and so
far, very limited, if any, effects on cardiovascular disease or on the
promotion of cancer have been reported. Interestingly, genistein,
which is the major phytoestrogen presence in soy, binds to estrogen
receptors, preferentially to estrogen receptor beta. We have previ-
ously shown that genistein, after binding to estrogen receptors,
activates a number of signalling pathways, particularly the MAPK
pathway which leads to the phosphorylation and thus activation of
NFκB. NFκB when entering the nucleus activates a transcription of a
number of longevity-associated genes such as glutathione peroxidase
or superoxide dismutase [19]. In this study, we tested whether
genistein couldmimic the favorable effect of estradiol in terms of their
direct protection of mitochondrial integrity and lowering of mito-
chondrial peroxide production. And indeed this was the case. As
shown in Figs. 4 and 5, genistein not only prevents mitochondrial
peroxide production, but also the liberation of cytochrome c from the
organelle. Therefore, phytoestrogens mimic the action of estrogens
and since they do not have their feminising and tumour promotion
properties, they constitute an excellent alternative to estradiol to
promote protection of mitochondria in a direct fashion.
The possible clinical relevance of genistein and other phytoestro-
gens to activate longevity-related genes (as we showed in previous
work, (see [19,34]) and to directly protect mitochondria remains to be
more closely studied.
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